Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CDN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,366
Award facts
- Contract value 100% obligated
- $15,366.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,366.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent pens on December 29, 2025, with completion due by December 30, 2025. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle designated SPE2DX and running through December 2026. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards. Performance will occur at the company's corporate headquarters in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company supplies an extensive portfolio of pharmaceutical products and medical devices across multiple therapeutic domains through its contracts with the Defense Logistics Agency and affiliated entities including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for specialty immunology medication aligns with the company's broad mandate to provide brand-name and generic medications, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9CDN?
SPE2DR26F9CDN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9CDN worth?
The government has obligated $15,366 on SPE2DR26F9CDN.
Is contract SPE2DR26F9CDN an order under another contract?
Yes. SPE2DR26F9CDN is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CDN competed?
The extent of competition for SPE2DR26F9CDN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award